Clinical Trials

Other solid neoplasm

Advanced Refractory Solid Tumors

NCT05959356 2025-12-17

CEIL

198 enrolled

Colorectal Neoplasms

NCT07159191 2025-09-08

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

30 enrolled

Genitourinary

Advanced Renal Cell Carcinoma (aRCC)

NCT07142863 2025-08-27

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

23 enrolled

Sarcoma

Osteosarcoma

NCT06772233 2025-07-31

A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

100 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07003815 2025-06-04

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

62 enrolled

Biliary Tract Neoplasms

NCT05112991 2025-05-29

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

108 enrolled

Gynecologic

Endometrial Neoplasms

NCT05941325 2025-05-18

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Sarcoma

NCT06791083 2025-01-24

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Stomach Neoplasms

NCT06692491 2024-11-18

SPRING

200 enrolled

Rare Tumour

NCT04910386 2024-08-14

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

126 enrolled

Biliary Tract Neoplasms

NCT05068427 2024-08-07

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Phase 2 Completed

34 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06498622 2024-07-12

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

45 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular

NCT04480502 2024-05-17

ENVASARC

207 enrolled

Sarcoma

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT06014372 2024-04-12

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

55 enrolled

Colonic Neoplasms

NCT06321081 2024-03-20

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

60 enrolled

Colorectal Neoplasms

NCT06301828 2024-03-08

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

16 enrolled

Gastrointestinal Neoplasms

NCT06202014 2024-01-19

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

43 enrolled

Pancreatic Neoplasms

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

38 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06108726 2023-10-31

A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer

16 enrolled

NSCLC

NCT06060704 2023-10-11

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

33 enrolled

Colorectal Neoplasms

NCT05969847 2023-08-01

TRACE-LE

72 enrolled

Rectal Neoplasms

NCT05203276 2023-06-22

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Lung Neoplasms

NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

36 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05552651 2022-09-23

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT05551247 2022-09-22

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

30 enrolled

Colorectal Neoplasms

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05422183 2022-06-16

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Gynecologic

Carcinoma, Ovarian Epithelial

NCT05417230 2022-06-14

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

29 enrolled

Biliary Tract Neoplasms

NCT05414630 2022-06-10

A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05385185 2022-05-23

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

CNS

Meningeal Carcinomatosis

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05335460 2022-04-19

To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

36 enrolled

Colonic Neoplasms

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

46 enrolled

Squamous Non-small Cell Lung Cancer

NCT04182789 2019-12-02

CPOG035-01

Neoplasms, Multiple Primary

NCT04034823 2019-07-26

KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer